324 related articles for article (PubMed ID: 28939378)
21. Polymorph screening of an active material.
Láng P; Kiss V; Ambrus R; Farkas G; Szabó-Révész P; Aigner Z; Várkonyi E
J Pharm Biomed Anal; 2013 Oct; 84():177-83. PubMed ID: 23845379
[TBL] [Abstract][Full Text] [Related]
22. Development of a targeted polymorph screening approach for a complex polymorphic and highly solvating API.
Campeta AM; Chekal BP; Abramov YA; Meenan PA; Henson MJ; Shi B; Singer RA; Horspool KR
J Pharm Sci; 2010 Sep; 99(9):3874-86. PubMed ID: 20575000
[TBL] [Abstract][Full Text] [Related]
23. Polymorphism and crystallization of active pharmaceutical ingredients (APIs).
Lu J; Rohani S
Curr Med Chem; 2009; 16(7):884-905. PubMed ID: 19275600
[TBL] [Abstract][Full Text] [Related]
24. The computational prediction of pharmaceutical crystal structures and polymorphism.
Price SL
Adv Drug Deliv Rev; 2004 Feb; 56(3):301-19. PubMed ID: 14962583
[TBL] [Abstract][Full Text] [Related]
25. Concerted molecular displacements in a thermally-induced solid-state transformation in crystals of DL-norleucine.
Anwar J; Tuble SC; Kendrick J
J Am Chem Soc; 2007 Mar; 129(9):2542-7. PubMed ID: 17286403
[TBL] [Abstract][Full Text] [Related]
26. General principles of pharmaceutical solid polymorphism: a supramolecular perspective.
Rodríguez-Spong B; Price CP; Jayasankar A; Matzger AJ; Rodríguez-Hornedo N
Adv Drug Deliv Rev; 2004 Feb; 56(3):241-74. PubMed ID: 14962581
[TBL] [Abstract][Full Text] [Related]
27. Characterization of pharmaceutical polymorphs by isothermal calorimetry.
Urakami K
Curr Pharm Biotechnol; 2005 Jun; 6(3):193-203. PubMed ID: 15974974
[TBL] [Abstract][Full Text] [Related]
28. Chemometrics-assisted solid-state characterization of pharmaceutically relevant materials. Polymorphic substances.
Calvo NL; Maggio RM; Kaufman TS
J Pharm Biomed Anal; 2018 Jan; 147():518-537. PubMed ID: 28668295
[TBL] [Abstract][Full Text] [Related]
29. Insight to the thermodynamic stability of molecular crystals through crystallographic studies of a multipolymorph system.
Ng AT; Lai C; Dabros M; Gao Q
J Pharm Sci; 2014 Nov; 103(11):3423-3431. PubMed ID: 25252084
[TBL] [Abstract][Full Text] [Related]
30. Impact of solid state properties on developability assessment of drug candidates.
Huang LF; Tong WQ
Adv Drug Deliv Rev; 2004 Feb; 56(3):321-34. PubMed ID: 14962584
[TBL] [Abstract][Full Text] [Related]
31. Metastability and transformation of polymorphic crystals in biodegradable poly(butylene adipate).
Gan Z; Kuwabara K; Abe H; Iwata T; Doi Y
Biomacromolecules; 2004; 5(2):371-8. PubMed ID: 15002996
[TBL] [Abstract][Full Text] [Related]
32. Characterization of polymorphic ampicillin forms.
Baraldi C; Tinti A; Ottani S; Gamberini MC
J Pharm Biomed Anal; 2014 Nov; 100():329-340. PubMed ID: 25194347
[TBL] [Abstract][Full Text] [Related]
33. The contribution of Raman spectroscopy to the analysis of phase transformations in pharmaceutical compounds.
Hédoux A; Guinet Y; Descamps M
Int J Pharm; 2011 Sep; 417(1-2):17-31. PubMed ID: 21256937
[TBL] [Abstract][Full Text] [Related]
34. Experimental cocrystal screening and solution based scale-up cocrystallization methods.
Malamatari M; Ross SA; Douroumis D; Velaga SP
Adv Drug Deliv Rev; 2017 Aug; 117():162-177. PubMed ID: 28811184
[TBL] [Abstract][Full Text] [Related]
35. The solid-state continuum: a perspective on the interrelationships between different solid-state forms in drug substance and drug product.
Elder DP; Patterson JE; Holm R
J Pharm Pharmacol; 2015 Jun; 67(6):757-72. PubMed ID: 25124049
[TBL] [Abstract][Full Text] [Related]
36. Efficient co-crystal screening using solution-mediated phase transformation.
Zhang GG; Henry RF; Borchardt TB; Lou X
J Pharm Sci; 2007 May; 96(5):990-5. PubMed ID: 17455356
[TBL] [Abstract][Full Text] [Related]
37. Impact of polymers on the crystallization and phase transition kinetics of amorphous nifedipine during dissolution in aqueous media.
Raina SA; Alonzo DE; Zhang GG; Gao Y; Taylor LS
Mol Pharm; 2014 Oct; 11(10):3565-76. PubMed ID: 25185035
[TBL] [Abstract][Full Text] [Related]
38. Polymorph selection: the role of nucleation, crystal growth and molecular modeling.
Erdemir D; Lee AY; Myerson AS
Curr Opin Drug Discov Devel; 2007 Nov; 10(6):746-55. PubMed ID: 17987526
[TBL] [Abstract][Full Text] [Related]
39. Solid-solid phase transitions: interface controlled reactivity and formation of intermediate structures.
Leoni S
Chemistry; 2007; 13(36):10022-9. PubMed ID: 17999395
[TBL] [Abstract][Full Text] [Related]
40. New technology for the investigation of water vapor sorption-induced crystallographic form transformations of chemical compounds: a water vapor sorption gravimetry-dispersive Raman spectroscopy coupling.
Feth MP; Jurascheck J; Spitzenberg M; Dillenz J; Bertele G; Stark H
J Pharm Sci; 2011 Mar; 100(3):1080-92. PubMed ID: 20740677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
